OncoCyte : Results of Operations and Financial Condition - Form 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | April 5, 2023
Source: marketscreener.com
Insight Genetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Insight Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Insight Genetics Today - Breaking & Trending Today
Oncocyte Corporation Announces Pricing of Public Offering
IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), announced today the pricing of an...
Source: globenewswire.com
Oncocyte Corporation Announces Pricing of Registered Direct
IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company...
Source: globenewswire.com
Oncocyte Corporation Announces Proposed Public Offering of
IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), announced today that it has...
Source: globenewswire.com
Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock
Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock IRVINE, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it has priced the previously announced underwritten public offering of 7,780,000 shares of its common stock, at a public offering price of $4.50 per share. The gross proceeds to the Company from this offering are expected to be approximately $35.0 million, before dedu...
Source: forextv.com